Mediclinic International plc Mediclinic CEO announces planned retirement (9498L)
25 July 2017 - 4:30PM
UK Regulatory
TIDMMDC
RNS Number : 9498L
Mediclinic International plc
25 July 2017
Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic" or "the Company")
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.
25 July 2017
MEDICLINIC CEO ANNOUNCES PLANNED RETIREMENT
The Company announces that on 24 July 2017, Mr Danie Meintjes
informed the Board of his intention to retire from his position as
Chief Executive Officer and a director of the Company by 31 July
2018. The Nomination Committee will begin a search to identify a
successor, to facilitate a smooth transition. Updates on this
process will be announced when appropriate.
Mr Meintjes (aged 61) joined the group in 1985 as the Hospital
Manager of Mediclinic Sandton. He became a member of Mediclinic
International Limited's Executive Committee in 1995 and a director
in 1996. Seconded to the company's operations in Dubai in 2006 and
appointed as the Chief Executive Officer of Mediclinic Middle East
in 2007, he was named Chief Executive Officer of Mediclinic
International Limited in 2010. Following its combination with Al
Noor Hospitals Group plc, Mr Meintjes became Chief Executive
Officer of the enlarged group in February 2016.
Dr Edwin Hertzog, Chairman of Mediclinic, said: "Danie has been
instrumental to the development of Mediclinic and the
implementation of our strategy over 20 years of service to the
group. We look forward to continuing to work with him over the
coming twelve months and wish him well."
Mr Meintjes said: "It has been a great privilege to have been in
a position to shape the success of Mediclinic. The Company is in a
strong position and has excellent prospects for growth. I thank all
my colleagues at Mediclinic for the part they play in meeting the
challenges to our business and upholding the highest standards of
clinical governance and ethical behaviour across our
platforms."
About Mediclinic International plc
Mediclinic is an international private healthcare group with
operating platforms in Southern Africa (South Africa and Namibia),
Switzerland and the United Arab Emirates. Its core purpose is to
enhance the quality of life of patients by providing acute care,
specialist-orientated, multi-disciplinary healthcare services.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group
plc, a LSE listed and UK-based private healthcare group.
Mediclinic comprises 74 hospitals and 37 clinics. Mediclinic
Southern Africa operates 49 hospitals and 2 day clinics throughout
South Africa and 3 hospitals in Namibia with more than 8 000
inpatient beds in total; Hirslanden operates 16 private acute care
facilities and 4 clinics in Switzerland with more than 1 600
inpatient beds; and Mediclinic Middle East operates 6 hospitals and
31 clinics with more than 700 inpatient beds in the United Arab
Emirates.
During February 2016, the combination of the Company (previously
named Al Noor Hospitals Group plc), with operations mainly in Abu
Dhabi in the United Arab Emirates, and Mediclinic International
Limited was completed. Mediclinic International Limited was a South
African based international private healthcare group founded in
1983 and listed on the JSE, the South African stock exchange, since
1986, with operations in South Africa, Namibia, Switzerland and the
United Arab Emirates (mainly in Dubai). The combination resulted in
the renaming of the enlarged group to Mediclinic International
plc.
Mediclinic has a primary listing on the Main Market of the LSE,
with secondary listings on the JSE in South Africa and the NSX in
Namibia.
For further information, please contact:
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott (UK)
+44 (0)20 3727 1000
Frank Ford (South Africa)
+27 (0)21 487 9000
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH,
United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank
Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOASEUFALFWSEFW
(END) Dow Jones Newswires
July 25, 2017 02:30 ET (06:30 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024